Receipt of mRNA COVID-19 vaccines preconception and during pregnancy and risk of self-reported spontaneous abortions, CDC v-safe COVID-19 Vaccine Pregnancy Registry 2020-21

Lauren Head Zauche, Bailey Wallace, Ashley N Smoots, Christine K Olson, Titilope Oduyebo, Shin Y Kim, Emily E Peterson, Jun Ju, Jennifer Beauregard, Allen J Wilcox, Charles E Rose, Dana Meaney-Delman, Sascha R Ellington, Lauren Head Zauche, Bailey Wallace, Ashley N Smoots, Christine K Olson, Titilope Oduyebo, Shin Y Kim, Emily E Peterson, Jun Ju, Jennifer Beauregard, Allen J Wilcox, Charles E Rose, Dana Meaney-Delman, Sascha R Ellington

Abstract

Background There is continuing public concern about the safety of COVID-19 vaccination during pregnancy. While there is no compelling biological reason to expect that mRNA COVID-19 vaccination (either preconception or during pregnancy) presents a risk to pregnancy, data are limited. It is, however, well documented that SARS-CoV-2 infection during pregnancy is associated with severe illness and increased risk of adverse pregnancy outcomes. Among recognized pregnancies in high-income countries, 11-16% end in spontaneous abortion (SAB). Methods People enrolled in v-safe, a voluntary smartphone-based surveillance system, who received a COVID-19 vaccine preconception or during pregnancy were contacted by telephone to enroll in the v-safe pregnancy registry. V-safe pregnancy registry participants who received at least one dose of an mRNA COVID-19 vaccine preconception or prior to 20 weeks' gestation and who did not report a pregnancy loss before 6 completed weeks' gestation were included in this analysis to assess the cumulative risk of SAB using Life Table methods. Results Among 2,456 pregnant persons who received an mRNA COVID-19 vaccine preconception or prior to 20 weeks' gestation, the cumulative risk of SAB from 6-19 weeks' gestation was 14.1% (95% CI: 12.1, 16.1%). Using direct age standardization to the selected reference population, the age-standardized cumulative risk of SAB was 12.8% (95% CI: 10.8-14.8%). Conclusions When compared to the expected range of SABs in recognized pregnancies, these data suggest receipt of an mRNA COVID-19 vaccine preconception or during pregnancy is not associated with an increased risk of SAB. These findings add to accumulating evidence that mRNA COVID-19 vaccines during pregnancy are safe.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Inclusion Criteria: Receipt of mRNA COVID-19 vaccines preconception and during pregnancy and risk of self-reported spontaneous abortions, CDC v-safe COVID-19 Vaccine Pregnancy Registry 2020–21

References

    1. Zambrano LD, Ellington SR, Strid P, et al.Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 Infection by pregnancy status — United States, January 22–October 3, 2020. MMWR. 2020;69:1641–1647.
    1. Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ, 2021; 193(16):E540–E548.
    1. Allotey J, Stallings E, Bonet M, et al.Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320.
    1. Rossen LM, Ahrens KA, Branum AM. Trends in risk of pregnancy loss among US women, 1990–2011. Paediatr Perinat Epidemiol. 2018;32(1):19–29.
    1. Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Haberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019; 364.
    1. Lang K, Neuvo-Chiquero A. Trends in self-reported spontaneous abortions: 1970–2000. Demography. 2012; 49(3): 989–1009.
    1. Linnakaari R, Helle N, Mentula M, et al.Trends in the incidence, rate, and treatment of miscarriage- nationwide registry-study in Findland, 1998–2016. Hum Reprod. 2019; 34 (11): 2120–2128.
    1. Ammon Avalos L, Galindo C, Li DK. A systematic review to calculate background miscarriage rates using life table analysis. Birth Defects Res A Clin Mol Teratol. 2012;94(6):417–23.
    1. Wilcox AJ. Fertility and Pregnancy - An Epidemiologic Perspective, Oxford Univ Press, 2010. p 152
    1. Goldhaber MK, Fireman BH. The fetal life table revisited: Spontaneous abortion rates in three Kaiser Permenente cohorts. Epidemiology. 1991; 2(1): 33–39.
    1. Shimabukuro TT, Kim SY, Myers TR, et al.Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021; 384: 2273–2282.
    1. Centers for Disease Control and Prevention. V-safe active surveillance for COVID-19 vaccine safety. January 2021. Accessed June 15, 2021. .
    1. Centers for Disease Control and Prevention. V-safe pregnancy surveillance (amendment). 2021. Accessed June 15, 2021. .
    1. Department of Health and Human Services – 45 C.F.R. part 46, 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 U.S.C. Sect. 552a; 44 U.S.C. Sect. 3501 et seq. Accessed June 17, 2021. .
    1. Wang et al.Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertility and Sterility. 2003; 79(3): 577–584.
    1. Xu R, Chambers C. A sample size calculation for spontaneous abortion in observational studies. Reproductive Toxicology. 2011; 32: 490–493.
    1. Keyfitz N. 3.Sampling variance of standardized mortality rates. Hum Biol. 1966;38(3):309–17.
    1. Goldshtein I, Nevo D, Steinberg DM, et al.Association between BNT162b2 accination and incidence of SARS-CoV-2 infection in pregnant women. JAMA. Published onlineJuly12, 2021.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit